Table 1 – Types of vertigo (non-exhaustive list)[/caption]
Vomiting
In older people, dizziness significantly increases the risk of falls.7 Implementing appropriate interventions to address modifiable risk factors such as dizziness is of paramount importance. In cases of drug-induced dizziness, deprescribing can be considered if the medicine can be safely reduced, discontinued or substituted to prevent inappropriate prescribing cascades of potentially inappropriate medicines (PIM), especially in the context of older people.29
A national education program for pharmacists funded by the Australian Government under the Quality Use of Diagnostics, Therapeutics and Pathology program.[/caption]
The hypothalamus houses neurons that produce neuropeptides called orexin A and B, which were discovered in 1998, and represent one of the most exciting discoveries in sleep medicine.5,13–15 Orexin-producing neurons help us stay awake and alert, especially when we really need to focus, which is critical for survival.5,14 These neurons reach out to many brain areas that use other wakefulness messengers such as acetylcholine, dopamine, histamine, serotonin and noradrenaline. These areas ‘talk back’ to the hypothalamus, to further boost wakefulness signals.5 Similarly, the thalamus is an important region that also serves to relay wakefulness signals from the RAS.5
Another dual orexin receptor antagonist (DORA), vornorexant*, is under development and currently undergoing clinical trials.28 
Other medicines such as dimdazenil* (partial positive allosteric modulator at GABAA specific to alpha-1 and alpha-5 GABAA receptor subtypes)41 and zuranolone* (positive allosteric modulator for GABAA) have also been tested, with positive outcomes in trials. Zuranolone* is marketed overseas specifically for postnatal depression, but clinical trials for its use in insomnia are ongoing.40
Kristy Carter (she/her)
Louise Edwards (she/her) From the President: Integrate further into primary healthcare and work together
Earlier this year the outgoing Federal Health Minister Greg Hunt announced the government would allocate $345.7 million in the 2022–23 federal Budget for pharmacists in aged care.
HPV vaccine – protective and no riskier than placebo
HPV vaccine protects against cervical precancer in female adolescents and does not increase the risk of serious adverse effects.
This is the finding of Cochrane...
Greater collaboration and funding needed in pharmacy
Greater funding is needed to unite the pharmacy profession with other healthcare professionals. This was the powerful message that came out of PSA’s NSW/ACT...
Rural pharmacists urged to have their say
Recent research has predicted by 2026 there could be just 52 pharmacists per 100,000 people in rural and remote areas, compared with more than...
PSA submission calls for urgent action on rural healthcare
The Federal Government needs to create a Commonwealth Chief Pharmacist role and urgently develop a discussion paper to address rural pharmacy quality, access and...
Rethinking how we manage osteoarthritis pain
Alex Page, pharmacist at Outback Pharmacies and former winner of the PSA Award for QUM in Pain Management, and Joyce McSwan, Founder and Managing...
